Clinical Trials Browser

Phase 1/2 × Platinum Resistant Ovarian Cancer × Thoracic × Clear all

NCT03319628 2023-11-13

First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

Phase 1/2 Active not recruiting

GynecologicThoracic

Platinum Resistant Ovarian Cancer